Annual Cash & Cash Equivalents
$415.80 M
+$40.10 M+10.67%
31 December 2023
Summary:
Zimmer Biomet Holdings annual cash & cash equivalents is currently $415.80 million, with the most recent change of +$40.10 million (+10.67%) on 31 December 2023. During the last 3 years, it has fallen by -$386.30 million (-48.16%). ZBH annual cash & cash equivalents is now -71.51% below its all-time high of $1.46 billion, reached on 31 December 2015.ZBH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$569.00 M
+$148.90 M+35.44%
30 September 2024
Summary:
Zimmer Biomet Holdings quarterly cash and cash equivalents is currently $569.00 million, with the most recent change of +$148.90 million (+35.44%) on 30 September 2024. Over the past year, it has increased by +$276.90 million (+94.80%). ZBH quarterly cash and cash equivalents is now -93.53% below its all-time high of $8.79 billion, reached on 31 March 2015.ZBH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBH Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.7% | +94.8% |
| 3 y3 years | -48.2% | -38.1% |
| 5 y5 years | -23.4% | +11.0% |
ZBH Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -48.2% | +10.7% | -38.1% | +94.8% |
| 5 y | 5 years | -48.2% | +10.7% | -76.6% | +94.8% |
| alltime | all time | -71.5% | -93.5% | +3524.2% |
Zimmer Biomet Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $569.00 M(+35.4%) |
| June 2024 | - | $420.10 M(+6.9%) |
| Mar 2024 | - | $393.00 M(-5.5%) |
| Dec 2023 | $415.80 M(+10.7%) | $415.80 M(+42.3%) |
| Sept 2023 | - | $292.10 M(-8.7%) |
| June 2023 | - | $319.80 M(-3.1%) |
| Mar 2023 | - | $330.20 M(-12.1%) |
| Dec 2022 | $375.70 M(-0.6%) | $375.70 M(-31.1%) |
| Sept 2022 | - | $545.40 M(+41.1%) |
| June 2022 | - | $386.40 M(-11.3%) |
| Mar 2022 | - | $435.80 M(+15.3%) |
| Dec 2021 | $378.10 M(-52.9%) | $378.10 M(-58.9%) |
| Sept 2021 | - | $919.60 M(-11.8%) |
| June 2021 | - | $1.04 B(+43.9%) |
| Mar 2021 | - | $724.30 M(-9.7%) |
| Dec 2020 | $802.10 M(+29.8%) | $802.10 M(-17.1%) |
| Sept 2020 | - | $967.30 M(+35.6%) |
| June 2020 | - | $713.40 M(-70.7%) |
| Mar 2020 | - | $2.43 B(+293.9%) |
| Dec 2019 | $617.90 M(+13.8%) | $617.90 M(+20.6%) |
| Sept 2019 | - | $512.50 M(+27.1%) |
| June 2019 | - | $403.10 M(-31.3%) |
| Mar 2019 | - | $586.80 M(+8.1%) |
| Dec 2018 | $542.80 M(+3.5%) | $542.80 M(+3.5%) |
| Sept 2018 | - | $524.60 M(+9.0%) |
| June 2018 | - | $481.20 M(-72.7%) |
| Mar 2018 | - | $1.77 B(+236.7%) |
| Dec 2017 | $524.40 M(-17.3%) | $524.40 M(+9.1%) |
| Sept 2017 | - | $480.80 M(+6.8%) |
| June 2017 | - | $450.00 M(-56.7%) |
| Mar 2017 | - | $1.04 B(+63.9%) |
| Dec 2016 | $634.10 M(-56.5%) | $634.10 M(+33.4%) |
| Sept 2016 | - | $475.30 M(-51.3%) |
| June 2016 | - | $976.30 M(-2.1%) |
| Mar 2016 | - | $996.80 M(-31.7%) |
| Dec 2015 | $1.46 B(+34.7%) | $1.46 B(-0.5%) |
| Sept 2015 | - | $1.47 B(+3.0%) |
| June 2015 | - | $1.42 B(-83.8%) |
| Mar 2015 | - | $8.79 B(+711.7%) |
| Dec 2014 | $1.08 B(+0.2%) | $1.08 B(+12.0%) |
| Sept 2014 | - | $967.30 M(-0.1%) |
| June 2014 | - | $968.70 M(+9.7%) |
| Mar 2014 | - | $882.70 M(-18.3%) |
| Dec 2013 | $1.08 B | $1.08 B(+17.8%) |
| Sept 2013 | - | $917.40 M(+29.2%) |
| June 2013 | - | $709.90 M(+8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $657.00 M(-25.7%) |
| Dec 2012 | $884.30 M(+15.1%) | $884.30 M(+10.3%) |
| Sept 2012 | - | $801.50 M(+23.1%) |
| June 2012 | - | $651.00 M(-3.4%) |
| Mar 2012 | - | $674.00 M(-12.3%) |
| Dec 2011 | $768.30 M(+14.9%) | $768.30 M(+38.9%) |
| Sept 2011 | - | $553.00 M(-11.4%) |
| June 2011 | - | $624.10 M(+8.4%) |
| Mar 2011 | - | $575.60 M(-13.9%) |
| Dec 2010 | $668.90 M(-3.3%) | $668.90 M(-29.9%) |
| June 2010 | - | $953.70 M(+16.1%) |
| Mar 2010 | - | $821.20 M(+18.7%) |
| Dec 2009 | $691.70 M(+225.4%) | $691.70 M(+57.3%) |
| Sept 2009 | - | $439.70 M(+58.5%) |
| June 2009 | - | $277.50 M(+30.4%) |
| Mar 2009 | - | $212.80 M(+0.1%) |
| Dec 2008 | $212.60 M(-54.2%) | $212.60 M(-60.8%) |
| Sept 2008 | - | $542.40 M(+39.8%) |
| June 2008 | - | $388.10 M(-18.5%) |
| Mar 2008 | - | $476.00 M(+2.6%) |
| Dec 2007 | $463.90 M(+74.6%) | $463.90 M(+48.2%) |
| Sept 2007 | - | $313.00 M(-12.7%) |
| June 2007 | - | $358.70 M(+10.0%) |
| Mar 2007 | - | $326.00 M(+22.7%) |
| Dec 2006 | $265.70 M(+13.9%) | $265.70 M(-3.6%) |
| Sept 2006 | - | $275.60 M(-17.9%) |
| June 2006 | - | $335.80 M(-16.8%) |
| Mar 2006 | - | $403.80 M(+73.2%) |
| Dec 2005 | $233.20 M(+50.8%) | $233.20 M(+154.0%) |
| Sept 2005 | - | $91.80 M(+16.5%) |
| June 2005 | - | $78.80 M(+38.2%) |
| Mar 2005 | - | $57.00 M(-63.1%) |
| Dec 2004 | $154.60 M(+99.5%) | $154.60 M(+241.3%) |
| Sept 2004 | - | $45.30 M(-41.1%) |
| June 2004 | - | $76.90 M(-29.3%) |
| Mar 2004 | - | $108.70 M(+40.3%) |
| Dec 2003 | $77.50 M(+393.6%) | $77.50 M(-56.2%) |
| Sept 2003 | - | $177.00 M(+53.9%) |
| June 2003 | - | $115.00 M(+244.3%) |
| Mar 2003 | - | $33.40 M(+112.7%) |
| Dec 2002 | $15.70 M(-14.7%) | $15.70 M(-24.5%) |
| Sept 2002 | - | $20.80 M(-21.2%) |
| June 2002 | - | $26.40 M(+26.9%) |
| Mar 2002 | - | $20.80 M(+13.0%) |
| Dec 2001 | $18.40 M(>+9900.0%) | $18.40 M(-21.4%) |
| Sept 2001 | - | $23.40 M |
| Dec 2000 | $0.00 | - |
FAQ
- What is Zimmer Biomet Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Zimmer Biomet Holdings?
- What is Zimmer Biomet Holdings annual cash & cash equivalents year-on-year change?
- What is Zimmer Biomet Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Zimmer Biomet Holdings?
- What is Zimmer Biomet Holdings quarterly cash and cash equivalents year-on-year change?
What is Zimmer Biomet Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of ZBH is $415.80 M
What is the all time high annual cash & cash equivalents for Zimmer Biomet Holdings?
Zimmer Biomet Holdings all-time high annual cash & cash equivalents is $1.46 B
What is Zimmer Biomet Holdings annual cash & cash equivalents year-on-year change?
Over the past year, ZBH annual cash & cash equivalents has changed by +$40.10 M (+10.67%)
What is Zimmer Biomet Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ZBH is $569.00 M
What is the all time high quarterly cash and cash equivalents for Zimmer Biomet Holdings?
Zimmer Biomet Holdings all-time high quarterly cash and cash equivalents is $8.79 B
What is Zimmer Biomet Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, ZBH quarterly cash and cash equivalents has changed by +$276.90 M (+94.80%)